Earnings Preview: Regenxbio
Portfolio Pulse from Benzinga Insights
Regenxbio (NASDAQ:RGNX) is set to release its latest quarterly earnings report on August 2, 2023. Analysts estimate an earnings per share (EPS) of $-1.26. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $19.0, down 44.22% over the last 52-week period.

August 04, 2023 | 10:09 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Regenxbio's upcoming earnings release could potentially impact its stock price. The company's past earnings have shown a mixed effect on the share price. The stock is currently down 44.22% over the last 52-week period.
The upcoming earnings release is a significant event for any company and can have a substantial impact on its stock price. In the case of Regenxbio, its past earnings have shown a mixed effect on the share price, indicating that the market's reaction can be unpredictable. Furthermore, the stock has been on a downward trend over the past year, which could influence investor sentiment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100